Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients.
about
Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@en
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@nl
type
label
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@en
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@nl
prefLabel
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@en
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic and Pharmacody ...... , in Type 2 Diabetic Patients.
@en
P2093
P2860
P304
P356
10.1002/CPDD.276
P577
2016-06-08T00:00:00Z